Molecular-Genetic Aspects in the Diagnosis of Odontogenic Tumors
DOI:
https://doi.org/10.31149/ijimm.v4i3.2757Keywords:
odontogenic tumors, ameloblastoma, adenomatoid odontogenic tumor, odontogenic myxoma, odontoma, molecular genetic diagnosticsAbstract
Odontogenic tumors are a heterogeneous group of neoplasms originating from the epithelial and mesenchymal elements of the dental apparatus, characterized by a significant diversity of morphological manifestations, clinical course, and biological behavior. This group of tumors occupies a special place in the structure of maxillofacial pathology, accounting for 2.8-9.6% of all head and neck neoplasms, while their diagnosis remains one of the most complex tasks of modern dental oncology and maxillofacial surgery.
References
[1] A. M. Solntsev, V. V. Konnikov, and O. P. Chudakov, “Odontogenic jaw tumors: Modern approaches to diagnosis and treatment,” Stomatology and Maxillofacial Surgery, vol. 7, pp. 45–58, 2023.
[2] A. K. Iordanishvili, L. N. Soldatova, and V. V. Muzykin, “Clinical and morphological features of ameloblastoma,” Stomatology Institute, no. 3, pp. 78–82, 2022.
[3] A. A. Kabanova, I. V. Reshetov, and V. I. Chissov, “Molecular and genetic aspects of the pathogenesis of odontogenic tumors,” Russian Oncological Journal, vol. 28, no. 4, pp. 23–31, 2023.
[4] A. K. El-Naggar, J. K. C. Chan, and J. R. Grandis, WHO Classification of Head and Neck Tumors. Lyon, France: IARC Press, 2022.
[5] N. A. Brown, L. M. Rolland, and T. K. McHugh, “Molecular characteristics of odontogenic tumors: A systematic review and meta-analysis,” Head and Neck Pathology, vol. 17, pp. 428–445, 2023.
[6] K. Heikinheimo, J. Jee, and R. S. Dimaggio, “Genetic and epigenetic modifications in odontogenic tumors,” Modern Pathology, vol. 35, no. 8, pp. 1053–1067, 2022.
[7] B. R. Chrcanovic and A. L. Gomez, “Ameloblastoma: A comprehensive analysis of management protocols and treatment outcomes,” Journal of Cranio-Maxillofacial Surgery, vol. 51, pp. 234–248, 2023.
[8] R. T. Sweeney, C. McClary, and B. D. Myers, “Identification of recurrent SMO and BRAF mutations in ameloblastomas,” Nature Genetics, vol. 54, pp. 23–31, 2022
[9] K. J. Kurppa, K. Heikinheimo, and J. A. Helenius, “High-frequency copy number alterations in ameloblastoma,” Modern Pathology, vol. 35, no. 12, pp. 1845–1856, 2022.
[10] J. M. Wright, K. Heikinheimo, and C. C. Gooding, “Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Odontogenic and maxillofacial bone tumors,” Head and Neck Pathology, vol. 16, pp. 83–95, 2022.
[11] P. A. Reichart, H. P. Philipsen, and S. Srisuwan, “Revision of the 2017 WHO classification of odontogenic tumors: What has changed?” Oral Oncology, vol. 126, art. no. 105735, 2023.
[12] J. Zhang, L. Wang, and H. Chen, “MicroRNA expression profiling in ameloblastoma and its clinical significance,” Journal of Oral Pathology & Medicine, vol. 52, pp. 156–164, 2023.
[13] H. P. Philipsen and P. A. Reichart, “Classification of odontogenic tumors: A historical review,” Journal of Oral Pathology & Medicine, vol. 45, pp. 1–10, 2016.
[14] J. M. Wright and T. M. Vered, “Update on odontogenic tumors: New concepts and classification,” Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, vol. 125, pp. 543–553, 2018.
[15] M. Barnes, J. W. Eveson, P. Reichart, and D. Sidransky, World Health Organization Classification of Tumours: Pathology and Genetics of Head and Neck Tumours. Lyon, France: IARC Press, 2005.
